EFFECTIVENESS OF LILLY CONNECTED CARE PROGRAM IN IMPROVING GLYCEMIC MANAGEMENT AMONG CHINESE TYPE 2 DIABETES PATIENTS: A RETROSPECTIVE REAL-WORLD STUDY
作者全名："Su, B.; Chen, Y.; Shen, X.; Guo, J.; Ding, Y.; Ma, X.; Yang, Y.; Liu, D."
作者地址："[Su, B.] Dalian Med Univ, Endocrinol, Hosp 2, Dalian, Liaoning, Peoples R China; [Su, B.] Dalian Med Univ, Dept Endocrinol, Hosp 2, Dalian, Liaoning, Peoples R China; [Chen, Y.; Guo, J.] Tianjin Med Univ, Dept Endocrinol, Hosp 2, Tianjin, Peoples R China; [Shen, X.] Xiamen Univ, Zhongshan Hosp, Dept Endocrinol, Xiamen, Fujian, Peoples R China; [Ding, Y.; Ma, X.; Yang, Y.] Eli Lilly Suzhou Pharmaceut Co Ltd, Lilly China Drug Dev & Med Affairs Ctr, Shanghai, Peoples R China; [Liu, D.] Chongqing Med Univ, Dept Endocrinol, Affiliated Hosp 2, Chongqing, Peoples R China"
通信作者：
来源：DIABETES TECHNOLOGY & THERAPEUTICS
ESI学科分类：CLINICAL MEDICINE
WOS号：WOS:000791214700022
JCR分区：Q1
影响因子：5.4
年份：2022
卷号：24
期号：
开始页：A9
结束页：A9
文献类型：Meeting Abstract
关键词：
摘要：
基金机构：
基金资助正文：
